Number of items in cart: 0
Abbott announced it has received approval from the U.S. Food and Drug Administration (FDA) for the use of the company’s Patient Controller app on compatible personal Apple smartphone devices. At Abbott, this approval allows patients living with neurological conditions, including chronic pain or movement disorders, the ability to manage therapy directly from their personal smartphone. […]
Medtronic plc, the global leader in medical technology, introduced the MiniMed™ Mio™ Advance infusion set to all Medtronic insulin pump customers in the United States. The MiniMed Mio Advance infusion set is the newest addition to the MiniMed™ portfolio of infusion sets and gives people using insulin pumps an optimal user experience with fewer steps1. […]
Becton, Dickinson and Company completed the acquisition of Straub Medical, which will further expands the company’s portfolio with a proven device with that’s approved with dual indications for arterial atherectomy and thrombectomy in the U.S. It has solid existing sales in Europe and China. The company is leveraging their strong existing channel and expertise in […]
Boston Scientific announced positive 12-month results from the PINNACLE FLX clinical trial assessing the safety and efficacy of the next-generation WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device for patients with nonvalvular atrial fibrillation (NVAF). Presented as a late-breaking clinical trial at HRS 2020 SCIENCE, the study evaluated performance of the WATCHMAN FLX device as […]
Abbott recently launched three diagnostics tests for COVID 19, including molecular tests on its ID NOW™ rapid point of care platform and m 2000 RealTime lab based platform, and a serology blood test for the detection of the antibody, IgG, on its lab based immunoassay platforms. Organic sales growth in the quarter was led by strong […]
Medtronic’s revenues increased by 2% to $30.56bn for FY19, which was below our guidance of $31.15bn for FY19. Revenues in Q4FY19 increased by $2mn to $8.14bn which adjusts for a $289mn negative impact from foreign currency No. of Pages – 44 Contents Executive Summary Financial Statements –Income Statement and Forecast –Balance Sheet –Cash Flow –Q4FY19 […]
TMO completed the acquisition of Brammer Bio, a leader in viral vector manufacturing for gene and cell therapies, for ~$1.7bn in cash. Brammer will become part of TMO’s Pharma Services business within its Laboratory Products and Services Segment. This acquisition will boost growth for the company and therefore, we expect 4% growth in revenues in […]
Abbott delivered strong Q1FY19 performance with 2% growth in revenues on reported basis and 7.1% growth in revenues on an organic basis. The growth was due to double-digit growth in FreeStyle Libre, MitraClip and Alinity. The adjusted EPS grew by 6.8% to $0.63 in Q1FY19 Number of pages – 41 Content: Executive Summary………………………………………………………..1 Financial Statements […]
